Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.04B | 34.93B | 31.25B | 30.14B | 27.47B | 26.00B |
Gross Profit | 6.46B | 6.91B | 6.00B | 5.84B | 5.40B | 5.33B |
EBITDA | 1.62B | 2.88B | 2.33B | 2.26B | 1.90B | 1.97B |
Net Income | 680.42M | 692.70M | 626.23M | 741.88M | 459.51M | 560.98M |
Balance Sheet | ||||||
Total Assets | 39.20B | 38.80B | 35.77B | 31.59B | 29.88B | 32.13B |
Cash, Cash Equivalents and Short-Term Investments | 11.19B | 10.62B | 10.89B | 10.18B | 10.73B | 11.26B |
Total Debt | 9.77B | 9.46B | 6.55B | 5.07B | 4.04B | 4.62B |
Total Liabilities | 17.77B | 17.06B | 14.46B | 10.96B | 9.43B | 10.38B |
Stockholders Equity | 21.43B | 21.74B | 21.31B | 20.62B | 20.45B | 21.75B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.72B | -2.09B | 404.53M | -1.33B | -221.59M |
Operating Cash Flow | 0.00 | 2.94B | 1.90B | 1.50B | 783.89M | 1.27B |
Investing Cash Flow | 0.00 | -4.45B | -3.05B | -1.33B | 203.25M | -1.40B |
Financing Cash Flow | 0.00 | 2.42B | 1.14B | -135.85M | -881.43M | 576.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥7.05B | 7.55 | 2.21% | 7.72% | 72.38% | ||
78 Outperform | ¥15.61B | 22.07 | 2.70% | 11.76% | 9.90% | ||
72 Outperform | ¥3.79B | 13.11 | 3.44% | 13.49% | 17.08% | ||
69 Neutral | ¥32.99B | 9.21 | 2.59% | 9.40% | -32.82% | ||
67 Neutral | €8.10B | 20.89 | 6.46% | 2.98% | 1.85% | -38.27% | |
67 Neutral | ¥3.23B | 12.60 | 5.21% | 1.87% | -33.27% | ||
61 Neutral | ¥8.86B | 56.69 | ― | 13.52% | -45.02% |